Inflammation

Items 31-40 of 1123

per page
Set Descending Direction
  1. (S)-Roscovitine
    CAS  186692-45-5
    AG-MR-C0002
    AG-MR-C0002-M0055 mg
    CHF 140.00
    AG-MR-C0002-M02525 mg
    CHF 560.00
    (S)-Roscovitine
  2. 10,11-Dehydrocurvularin
    CAS  1095588-70-7
    AG-CN2-0165
    AG-CN2-0165-M0011 mg
    CHF 140.00
    AG-CN2-0165-M0055 mg
    CHF 560.00
    10,11-Dehydrocurvularin
  3. 10Z-Hymenialdisine
    CAS  82005-12-7
    AG-CN2-0067
    AG-CN2-0067-C500500 µg
    CHF 270.00
    10Z-Hymenialdisine
  4. 16-epi-Latrunculin B
    CAS  444911-05-1
    AG-CN2-0034
    AG-CN2-0034-C100100 µg
    CHF 220.00
    16-epi-Latrunculin B
  5. 2,5-Dimethyl-celecoxib
    CAS  457639-26-8
    AG-CR1-3599
    AG-CR1-3599-M0055 mg
    CHF 75.00
    AG-CR1-3599-M02525 mg
    CHF 235.00
    2,5-Dimethyl-celecoxib
  6. 20S Immunoproteasome (human) (untagged)
    SBB-PP0004
    SBB-PP0004-C02525 µg
    CHF 404.00
    20S Immunoproteasome vs. 20S Constitutive Proteasome Activity: 20S immunoproteasome is most active against Suc-LLVY-AMC (SBB-PS0010), Ac-PAL-AMC (SBB-PS0007), and Ac-ANW-AMC (SBB-PS0009) substrates, representing physiologically relevant chymotrypsi
  7. 20S Immunoproteasome (human) (untagged)
    SBB-PP0144
    SBB-PP0144-C02525 µg
    CHF 507.00
    NEW 20S Immunoproteasome (human) (untagged)
  8. 20S Immunoproteasome (mouse) (untagged)
    SBB-PP0083
    SBB-PP0083-C02525 µg
    CHF 360.00
    20S Immunoproteasome (mouse) (untagged)
  9. 20S Immunoproteasome (rat) (untagged)
    SBB-PP0046
    SBB-PP0046-C05050 µg
    CHF 360.00
    20S Immunoproteasome (rat) (untagged)
  10. 20S Proteasome (human) (untagged)
    SBB-PP0005
    SBB-PP0005-C05050 µg
    CHF 278.00
    20S Immunoproteasome vs. 20S Constitutive Proteasome Activity: 20S Proteasome is most active against Suc-LLVY-AMC (SBB-PS0010), Z-LLE-AMC (SBB-PS0006), and Ac-WLA-AMC (SBB-PS0008) substrates, representing physiologically relevant chymotry

Items 31-40 of 1123

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.